Markets, business & the bigger picture. 🇺🇸
Breaking down earnings, market moves, and what matters to long-term investors.
Here to learn, share ideas, and foll
@teslaboomfans That’s a good point. If Tesla can keep scaling at that pace and prove the economics work, the market could start valuing $TSLA very differently.
Tesla rallied on Cybercab optimism. So why are investors getting nervous?
$TSLA’s latest pullback highlights a bigger question: Can Tesla deliver on its AI future fast enough to justify its valuation?
Here’s what shareholders should be watching:
• Growth: Will Cybercab and robotaxis scale as quickly as promised?
• Spending: Tesla cut its 2026 capex outlook to $20B from over $25B. Is this better cost control—or a sign of slower execution?
• Regulation: Could safety scrutiny delay Cybercab’s rollout?
• Valuation: How much future success is already priced into the stock?
After the rally, profit-taking may add pressure. But the bigger concern is whether Tesla’s future businesses can turn into real, sustainable profits.
If you’re holding $TSLA, what worries you most: valuation, execution, or regulation?
#TSLA #Tesla #Cybercab #Robotaxi
The next 2020-style run? Possible — but Tesla needs more than hype this time.
The next leg up will likely depend on execution: FSD adoption, robotaxi expansion, energy storage growth, and whether margins can hold up.
The question isn’t just if $TSLA can rally again — it’s what will drive it.
@kayla41rx7 Agreed. Cybercab could be a big deal for Tesla, but I want to see it actually make money before getting too excited. A lot of that potential seems priced in already.
@NathanCrossNC Wall Street is raising targets, but the wide range of valuations tells me uncertainty is still high. I’d watch the fundamentals, not just the headlines.
@rektfencer A key support level matters — but fundamentals matter more. If semis break down, is it a warning about AI demand, or just a valuation reset?
@0xLofty A bubble can exist alongside a real technological revolution. The key isn’t whether AI changes the world — it’s whether today’s valuations can justify the earnings that follow.
$EVAX is back on investors’ radar. Could the next catalyst spark another rally?
Evaxion’s personalized cancer vaccine, EVX-01, has reported encouraging 3-year follow-up results in melanoma patients.
Why it matters:
• Clinical progress: Sustained responses could strengthen the case for further development.
• Potential catalyst: New data at the Oct. 24 ESMO meeting may draw fresh attention to the stock.
• The risk: EVX-01 is still in Phase 2. Promising results don’t guarantee success in larger trials—or commercial approval.
$EVAX has already shown how quickly biotech news can move a small-cap stock. Another rally is possible, but so is a sharp reversal if expectations get ahead of the evidence.
Will new data fuel another breakout—or has the optimism already been priced in?
#EVAX #Biotech #CancerResearch #Stocks
@0xPhantomDefi Interesting thesis, but a potential $TSLA–SpaceX merger is still speculation. I’d focus on confirmed fundamentals and valuation rather than trying to predict a “final crash” or time the bottom.
@JasonL_Capital The AI infrastructure thesis makes sense, but strong growth doesn’t automatically mean strong returns. A lot depends on valuation, capital intensity, and how much future growth is already priced in. Great companies can still be poor investments at the wrong price.
Nvidia’s rally is the headline. The bigger story is what comes next.
AI spending is expanding beyond GPUs into networking, systems, and software.
But here’s the real question: Can AI spending generate returns fast enough to justify the investment?
Demand is one side of the story. Profitability is the other.
Is the market underestimating $NVDA’s long-term opportunity—or overlooking the risks?
#NVDA #AI #Stocks
🚨 Why Would Musk Want to Merge Tesla and SpaceX?
It’s bigger than cars and rockets.
⚡ Tesla brings AI, robotics, batteries and manufacturing.
🚀 SpaceX brings Starlink, launch technology and ambitions for orbital AI data centers.
The goal? Potentially combine chips, computing power, energy and connectivity under one roof.
But there’s a catch: shareholder approval, regulatory scrutiny and execution risks remain major hurdles. No deal is guaranteed.
Could this reshape the future of AI and space technology—or create too much complexity?
#Tesla #SpaceX #AI #Robotics #Investing
🚨 Space Stocks Update: The Satellite Race Is Heating Up 🚀
🛰️ $ASTS — Four major European telecom operators are exploring a joint bid for satellite spectrum. ASTS works with all four, but the satellite partner for this initiative has not yet been selected.
🚀 $RKLB — Rocket Lab now expects Neutron’s first launch in 2027.
📡 SpaceX / Starlink — SpaceX announced a deal to acquire additional US wireless spectrum for Starlink Mobile, pending final FCC approval.
Three major developments. One increasingly competitive space industry.
👀 Which story are you watching most closely?
#ASTS #RKLB #SpaceX #SpaceStocks #USStocks
@adamha4freedom Good question! There are other launch providers out there, but I’m curious who they’ll partner with. Rocket Lab could be one to watch, though nothing’s confirmed yet. Who do you think it’ll be?
🚨 ASTS Jumps Overnight: Is a Telecom Deal on the Horizon? 🛰️
AST SpaceMobile ($ASTS) is back in focus after Boost Mobile’s founder expressed interest in buying the company.
💡 A potential acquisition, JV, or global telecom alliance could help carriers compete with SpaceX.
📈 The opportunity: Growing demand for satellite-to-phone connectivity.
⚠️ The risk: No confirmed deal, plus execution challenges and intensifying competition.
Will telecom giants make a move on ASTS—or is this just speculation?
#ASTS #SpaceStocks #Telecom #SpaceX #USStocks